# US 2012/0252018 A1 · Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252018 A1
- Document ID: US20120252018A1
- Status: Published application
- Kind: A1
- Application number: 13/442,717
- Filed: 2012-04-09
- Published: 2012-10-04
- Earliest claimed: 1999-05-07
- Assignees: Life Technologies Corporation
- Inventors: Marcel P. Bruchez; R. Hugh Daniels; Stephen A. Empedocles; Vince E. Phillips; Edith Y. Wong; Donald A. Zehnder
- Web page: https://patentgrep.com/patent/US20120252018A1

## CPC

- G01N 33/54346: {Nanoparticles}
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- G01N 33/533: with fluorescent label
- G01N 33/588: {with semiconductor nanocrystal label, e.g. quantum dots}
- G01N 2458/00: Labels used in chemical analysis of biological material
- Y10S 977/924: using nanostructure as support of dna analysis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The use of semiconductor nanocrystals as detectable labels in various chemical and biological applications is disclosed. The methods find use for detecting a single analyte, as well as multiple analytes by using more than one semiconductor nanocrystal as a detectable label, each of which emits at a distinct wavelength.

## Claims

### Claim 1

A method of detecting one or more target analytes in a sample, comprising:
(a) providing a sample containing or suspected of containing the one or more target analytes on a solid support;
(b) combining said sample with a semiconductor nanocrystal conjugate, wherein said combining is performed under conditions that allow formation of a complex comprising said conjugate and said analyte, when present;
(c) removing any unbound conjugate; and
(d) detecting the presence of the complex, if present, by monitoring a spectral emission mediated by the semiconductor nanocrystal in the complex, wherein the emission indicates the presence of one or more target analytes in the sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the sample comprises a plurality of target analytes, and the method further comprises:
(a) providing a conjugate specific for each target analyte, wherein each semiconductor nanocrystal conjugate has an emission spectrum distinct from the other semiconductor nanocrystal conjugates; and
(b) detecting the presence of the target analytes by monitoring the spectral emissions of the sample, wherein the emissions indicate the presence of the target analytes in the sample.

### Claim 3 (depends on 1)

The method of claim 1, wherein the one or more analytes is a nucleic acid molecule.

### Claim at position 4

-10. (canceled)

### Claim 11 (depends on 3)

The method of claim 3, wherein the nucleic acid molecule is a polynucleotide.

### Claim at position 6

-16. (canceled)

### Claim 17

A method of detecting one or more target analytes in a sample, comprising:
(a) providing an unlabeled specific-binding molecule on a solid support;
(b) combining a sample containing one or more target analytes or suspected of containing the one or more analytes with said specific-binding molecule, wherein said combining is performed under conditions that allow formation of a first complex comprising said specific-binding molecule and said analyte, when present;
(c) removing any unbound sample;
(d) combining said first complex with a semiconductor nanocrystal conjugate, wherein said combining is performed under conditions that allow formation of a second complex comprising said conjugate and said analyte, when present;
(e) removing any unbound conjugate; and
(f) detecting the presence of the second complex, if present, by monitoring a spectral emission mediated by the semiconductor nanocrystal in the second complex, wherein the emission indicates the presence of one or more target analytes in the sample.

### Claim 18 (depends on 17)

The method of claim 17, wherein the method comprises combining a sample comprising a plurality of target analytes with the specific-binding molecule, wherein the method further comprises:
(a) providing an unlabeled specific-binding molecule on a solid support specific for each target analyte and providing a semiconductor nanocrystal conjugate specific for each target analyte, wherein each semiconductor nanocrystal conjugate has an emission spectrum distinct from the other semiconductor nanocrystal conjugates; and
(b) detecting the presence of the target analytes by monitoring the spectral emissions of the sample, wherein the emissions indicate the presence of the target analytes in the sample.

### Claim 19 (depends on 17)

The method of claim 17, wherein the one or more analytes is a nucleic acid molecule.

### Claim 20 (depends on 19)

The method of claim 19, wherein the nucleic acid molecule is a polynucleotide.

### Claim at position 11

-24. (canceled)

### Claim 25

A method of detecting one or more target analytes in a sample, comprising:
(a) providing a sample containing one or more target analytes or suspected of containing the one or more analytes on a solid support;
(b) combining with said sample a specific-binding molecule, wherein (i) said specific-binding molecule comprises a first member of a binding pair, and (ii) said combining is performed under conditions that allow formation of a first complex comprising said specific-binding molecule and said analyte, when present;
(c) removing any unbound specific-binding molecule;
(d) combining said first complex with a second member of the binding pair, wherein (i) said second member of the binding pair is linked to a first semiconductor nanocrystal; and (ii) said combining is performed under conditions that allow formation of a second complex comprising the binding pair and said one or more analytes; and
(e) detecting the presence of the second complex, if present, by monitoring a spectral emission mediated by the semiconductor nanocrystal in the second complex, wherein the emission indicates the presence of one or more target analytes in the sample.

### Claim 26 (depends on 25)

The method of claim 25, wherein the one or more analytes is a nucleic acid molecule.

### Claim at position 14

-29. (canceled)

### Claim 30 (depends on 25)

The method of claim 25, wherein the one or more analytes is a polynucleotide.

### Claim 31 (depends on 25)

The method of claim 25, wherein the specific-binding molecule is a polymerase chain reaction amplification product.

### Claim at position 17

-34. (canceled)

### Claim 35 (depends on 25)

The method of claim 25, wherein the first member of the binding pair is biotin and the second member of the binding pair is streptavidin or the first member of the binding pair is biotin and the second member of the binding pair is streptavidin.

### Claim 36

(canceled)

### Claim 37 (depends on 25)

The method of claim 25, wherein the first member of the binding pair is digoxygenin and the second member of the binding pair is an antibody directed against digoxygenin or the first member of the binding pair is fluorescein and the second member of the binding pair is an antibody directed against fluorescein.

### Claim at position 21

-45. (canceled)

### Claim 46 (depends on 1)

The method of claim 1, wherein the solid support is selected from a membrane, bead, microsphere, and microtiter well or plate.

### Claim 47 (depends on 17)

The method of claim 17, wherein the solid support is selected from a membrane, bead, microsphere, and microtiter well or plate.

### Claim 48 (depends on 17)

The method of claim 17, wherein the specific-binding molecule is a polymerase chain reaction amplification product.

### Claim 49 (depends on 25)

The method of claim 25, wherein the solid support is selected from a membrane, bead, microsphere, and microtiter well or plate.

### Claim 50 (depends on 31)

The method of claim 31, wherein the first member of the binding pair is incorporated in the amplification product.
